efavirenz has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baranzini, M; Bellisai, C; Cirilli, R; Giovannini, D; Lavia, P; Milite, C; Pichierri, P; Pugliese, GM; Rovella, P; Sbardella, G; Sciamanna, I; Serafino, A; Sinibaldi-Vallebona, P; Spadafora, C; Trisciuoglio, D; Zeya Ansari, MS | 1 |
Ellfolk, M; Gyllensten, K; Norlin, M; Wikvall, K | 1 |
2 other study(ies) available for efavirenz and Cancer of Prostate
Article | Year |
---|---|
Reverse transcriptase inhibitors promote the remodelling of nuclear architecture and induce autophagy in prostate cancer cells.
Topics: Alkynes; Autophagy; Benzoxazines; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclopropanes; DNA Damage; Humans; Male; PC-3 Cells; Prostatic Neoplasms; Pyrimidinones; Reverse Transcriptase Inhibitors | 2020 |
Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells.
Topics: Alkynes; Anti-HIV Agents; Anticonvulsants; Benzoxazines; Calcitriol; Cell Line; Cell Line, Tumor; Cholestanetriol 26-Monooxygenase; Constitutive Androstane Receptor; Cyclopropanes; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Fibroblasts; Humans; Male; Phenobarbital; Pregnane X Receptor; Prostatic Neoplasms; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Skin; Transcription Factors | 2009 |